CRYSTALLINE FORMS OF DERIVATIVE PYRROLIDONE, USEFUL IN TREATMENT OF ALZHEIMER'S DISEASE, AND THEIR OBTAINING

摘要

The present invention provides processes to manufacture crystalline N-[(3S)-1-[4-[(3-fluorophenyl)methoxy]phenyl]-5-oxo-pyrrolidin-3-yl]acetamide. Also disclosed are compounds useful as intermediates in the methods of the invention.